IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Condition: Acute Pyelonephritis Interventions: Drug: Omadacycline; Drug: Levofloxacin Sponsor: Paratek Pharmaceuticals Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials